type 2 diabetes

Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Pharmaceutical Business Review
Mon, 02/24/20 - 10:42 am
Eli Lilly
Trulicity
FDA
type 2 diabetes
Cardiovascular
Preclinical Data Shows Potential Path to Reverse Type-2 Diabetes and Liver Fibrosis
BioSpace
Tue, 02/11/20 - 10:41 am
Yale
type 2 diabetes
liver fibrosis
NDMA in Metformin: FDA Finds Low Levels in Only 2 of 10 Tested Products
RAPS.org
Tue, 02/4/20 - 10:23 am
NDMA
metformin
FDA
type 2 diabetes
diabetes
Novo Nordisk joins with UVA in diabetes digital simulation project
Pharmaforum
Fri, 12/20/19 - 12:08 pm
Novo Nordisk
UVA
R&D
type 2 diabetes
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Mon, 12/16/19 - 10:35 am
Jardiance
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
chronic heart failure
clinical trials
After Zantac scare, FDA targets generic metformin for carcinogen tests
Fierce Pharma
Thu, 12/5/19 - 11:45 pm
generics
FDA
type 2 diabetes
metformin
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
Tue, 12/3/19 - 09:50 am
AstraZeneca
diabetes
type 2 diabetes
heart failure
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
Tue, 11/5/19 - 10:22 am
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Thu, 10/24/19 - 10:55 am
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
J&J's suffering Invokana scores new kidney disease nod. Can it turn sales around?
Fierce Pharma
Mon, 09/30/19 - 11:47 pm
JNJ
Invokana
diabetic kidney disease
FDA
type 2 diabetes
Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus
Fierce Pharma
Fri, 09/20/19 - 01:13 pm
Novo Nordisk
oral semaglutide
FDA
Rybelsus
type 2 diabetes
Novo, e-therapeutics extend Type 2 diabetes research pact to include new genomics tech
Fierce Biotech
Thu, 08/1/19 - 10:35 am
Novo Nordisk
e-therapeutics
drug discovery
type 2 diabetes
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Yahoo/Reuters
Sat, 07/27/19 - 01:58 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
type 2 diabetes
diabetes
insulin
Lilly's Study on Higher Doses of Trulicity Meets Endpoint
Yahoo/Zacks.com
Thu, 06/27/19 - 06:43 pm
Eli Lilly
clinical trials
type 2 diabetes
Trulicity
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Pharmaforum
Tue, 06/18/19 - 10:10 am
Novo Nordisk
Victoza
type 2 diabetes
pediatric
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Fierce Biotech
Mon, 06/10/19 - 09:39 am
Eli Lilly
NASH
tirzepatide
clinial trials
ADA
type 2 diabetes
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Wed, 06/5/19 - 12:01 am
Novo Nordisk
type 2 diabetes
diabetes
chronic kidney disease
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Xtalks
Thu, 05/30/19 - 05:31 pm
diabetes
type 2 diabetes
insulin patch
ADA
Valeritas
V-Go
devices
Oramed spearheading human oral insulin trials in 37 US centers
CP Wire
Thu, 05/9/19 - 01:06 pm
Oramed
insulin
oral insulin
diabetes
type 2 diabetes
clinical trials

Pages